期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (1)
Previous studies reported that microRNA-1298 was abnormally expressed in the myocardium of rat hearts after hypoxia/normoxia injury. This study aims t......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (4)
The long-term prognosis of patients with chronic thromboembolic pulmonary hypertension (CTEPH) receiving different treatments is deserved to be analyz......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (2)
Emerging evidence indicates that circular RNA (circRNA) is implicated in the development of atherosclerosis (AS). This study investigated the effect o......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (2)
Objective Risk factors of left atrial thrombus (LAT) or spontaneous echo contrast (LASEC) in non-valvular atrial fibrillation (NVAF) had been reported......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 54 (1)
The current study aimed to elucidate the efficacy of interatrial shunt device (IASD) for the treatment of acute pulmonary hypertensive crisis (PHC) an......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 54 (3)
Approximately 31% of patients diagnosed with multiple myeloma (MM) have pre-existing hypertension, but its effects on patient survival have not been i......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (3)
Rivaroxaban, as a novel oral anticoagulant agent, emerged in thrombosis management. This study aimed to compare the efficacy and safety of once-daily ......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 54 (3)
Exosomes (exos) exert biological functions to maintain the dynamic balance of cells and tissues by transferring biological cargo to recipient cells. T......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (3)
The clinical symptoms of perforating arteries differ, and responses to intravenous thrombolytic therapy are heterogeneous. Here, we investigated the e......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (4)
This study aimed to explore antithrombotic strategy and its relationship with outcomes in patients with atrial fibrillation (AF) at high risk for stro......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 54 (3)
Central venous catheters can be used conveniently to deliver medications and improve comfort in patients with cancer. However, they can cause major co......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (3)
To assess the therapeutic efficacy of PDGF-D-overexpressing endothelial progenitor cells (EPCs) in deep vein thrombosis. Inferior vena cava thrombosis......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 54 (1)
Protein S deficiency is associated with an increased risk of thromboembolism, which may be caused by hereditary deficiency and several physiological a......
期刊： JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022; 53 (1)
Reperfusion may cause injuries to the myocardium in ischemia situation, which is called ischemia/reperfusion (I/R) injury. The study aimed to explore ......
